Geode Capital Management
ASMB icon

Geode Capital Management’s Assembly Biosciences ASMB Stock Holding History

Geode Capital Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.69M Buy
132,971
+1,664
+1% +$47.5K ﹤0.01% 2886
2025
Q4 		$4.47M Buy
131,307
+1,212
+0.9% +$39K ﹤0.01% 2842
2025
Q3 		$3.33M Buy
130,095
+79,080
+155% +$1.74M ﹤0.01% 2980
2025
Q2 		$925K Buy
51,015
+3,312
+7% +$43.7K ﹤0.01% 3349
2025
Q1 		$456K Buy
47,703
+1,068
+2% +$14K ﹤0.01% 3575
2024
Q4 		$736K Sell
46,635
-399
-0.8% -$6.42K ﹤0.01% 3474
2024
Q3 		$712K Sell
47,034
-7,375
-14% -$112K ﹤0.01% 3473
2024
Q2 		$747K Buy
54,409
+2,212
+4% +$31.5K ﹤0.01% 3416
2024
Q1 		$694K Buy
52,197
+1,196
+2% +$13.9K ﹤0.01% 3498
2023
Q4 		$502K Buy
51,001
+10,562
+26% +$100K ﹤0.01% 3608
2023
Q3 		$430K Sell
40,439
-1,865
-4% -$22.5K ﹤0.01% 3658
2023
Q2 		$584K Buy
42,304
+4,585
+12% +$56.3K ﹤0.01% 3579
2023
Q1 		$380K Hold
37,719
– – ﹤0.01% 3753
2022
Q4 		$588K Sell
37,719
-76
-0.2% -$1.3K ﹤0.01% 3589
2022
Q3 		$743K Buy
37,795
+4,913
+15% +$119K ﹤0.01% 3539
2022
Q2 		$828K Buy
32,882
+1,360
+4% +$31.3K ﹤0.01% 3508
2022
Q1 		$779K Sell
31,522
-11,425
-27% -$245K ﹤0.01% 3723
2021
Q4 		$1.2M Sell
42,947
-825
-2% -$27K ﹤0.01% 3627
2021
Q3 		$1.83M Buy
43,772
+4,413
+11% +$185K ﹤0.01% 3392
2021
Q2 		$1.83M Sell
39,359
-15,399
-28% -$763K ﹤0.01% 3304
2021
Q1 		$3.02M Buy
54,758
+17,187
+46% +$1.14M ﹤0.01% 3047
2020
Q4 		$2.73M Sell
37,571
-642
-2% -$75.3K ﹤0.01% 2911
2020
Q3 		$7.54M Buy
38,213
+1,063
+3% +$268K ﹤0.01% 2137
2020
Q2 		$10.4M Buy
37,150
+2,666
+8% +$622K ﹤0.01% 1906
2020
Q1 		$6.14M Buy
34,484
+6,180
+22% +$1.32M ﹤0.01% 2019
2019
Q4 		$6.95M Buy
28,304
+3,882
+16% +$715K ﹤0.01% 2259
2019
Q3 		$2.88M Buy
24,422
+401
+2% +$60.7K ﹤0.01% 2717
2019
Q2 		$3.89M Buy
24,021
+2,730
+13% +$519K ﹤0.01% 2547
2019
Q1 		$5.03M Buy
21,291
+2,285
+12% +$579K ﹤0.01% 2334
2018
Q4 		$5.16M Buy
19,006
+1,005
+6% +$291K ﹤0.01% 2204
2018
Q3 		$8.02M Buy
18,001
+4,102
+30% +$1.92M ﹤0.01% 2074
2018
Q2 		$6.54M Sell
13,899
-220
-2% -$116K ﹤0.01% 2156
2018
Q1 		$8.32M Buy
14,119
+167
+1% +$104K ﹤0.01% 1892
2017
Q4 		$7.58M Buy
13,952
+3,163
+29% +$1.43M ﹤0.01% 1943
2017
Q3 		$4.52M Buy
10,789
+531
+5% +$163K ﹤0.01% 2260
2017
Q2 		$2.54M Buy
10,258
+2,094
+26% +$590K ﹤0.01% 2594
2017
Q1 		$2.5M Buy
8,164
+1,994
+32% +$489K ﹤0.01% 2536
2016
Q4 		$899K Buy
6,170
+140
+2% +$20.8K ﹤0.01% 3046
2016
Q3 		$521K Buy
6,030
+4
+0.1% +$309 ﹤0.01% 3231
2016
Q2 		$401K Sell
6,026
-1,284
-18% -$84.3K ﹤0.01% 3310
2016
Q1 		$440 Buy
7,310
+98
+1% +$6.55K ﹤0.01% 3292
2015
Q4 		$649K Buy
7,212
+84
+1% +$9.15K ﹤0.01% 3139
2015
Q3 		$817K Buy
7,128
+243
+4% +$42.7K ﹤0.01% 2981
2015
Q2 		$1.59M Buy
6,885
+2,029
+42% +$392K ﹤0.01% 2634
2015
Q1 		$771K Buy
4,856
+1,766
+57% +$239K ﹤0.01% 3001
2014
Q4 		$291K Buy
3,090
+2
+0.1% +$197 ﹤0.01% 3423
2014
Q3 		$303K Buy
3,088
+1,818
+143% +$161K ﹤0.01% 3396
2014
Q2 		$99K Sell
1,270
-1
-0.1% -$71 ﹤0.01% 3697
2014
Q1 		$97K Buy
1,271
+370
+41% +$57.6K ﹤0.01% 3668
2013
Q4 		$206K Buy
901
+1
+0.1% +$182 ﹤0.01% 3418
2013
Q3 		$156K Buy
900
+2
+0.2% +$306 ﹤0.01% 3389
2013
Q2 		$129K Buy
+898
New +$141K ﹤0.01% 3364

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Geode Capital Management's ASMB Position: Q1 2026 in Review

Geode Capital Management increased its Assembly Biosciences (ASMB) stake by 1.3% in Q1 2026, buying an estimated $47.5K and bringing the position to 132,971 shares worth $3.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2886.

Geode Capital Management first reported a position in ASMB in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.4M in Q2 2020. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Geode Capital Management held 132,971 shares of Assembly Biosciences worth $3.69M as of Q1 2026.
  • Geode Capital Management bought 1,664 Assembly Biosciences shares in Q1 2026, an estimated $47.5K.
  • Assembly Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2886 holding.
  • Geode Capital Management first reported a position in Assembly Biosciences in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's Assembly Biosciences position peaked at $10.4M in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.